The Q4 earnings report for Aligos Therapeutics (NASDAQ:ALGS) was released on Thursday, March 5, 2026 at 08:00 AM.
Here’s what investors need to know about the latest announcement.
Earnings
Aligos Therapeutics beat estimated earnings by 18.03%, reporting an EPS of $-1.91 versus an estimate of $-2.33.
Revenue was down $460 thousand from the same period last year.
Historical Earnings Summary
The company missed on EPS by …